Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.84 EUR
Market Cap: 55m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shedir Pharma Srl Unipersonale
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Other Operating Expenses
-€17.6m
CAGR 3-Years
-11%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Other Operating Expenses
€6.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
27%
P
Pierrel SpA
MIL:PRL
Other Operating Expenses
-€1.6m
CAGR 3-Years
-20%
CAGR 5-Years
-13%
CAGR 10-Years
9%
Friulchem SpA
MIL:FCM
Other Operating Expenses
€1.8m
CAGR 3-Years
119%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.26 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Other Operating Expenses?
Other Operating Expenses
-17.6m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Other Operating Expenses amounts to -17.6m EUR.

What is Shedir Pharma Srl Unipersonale's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-3%

Over the last year, the Other Operating Expenses growth was -25%. The average annual Other Operating Expenses growth rates for Shedir Pharma Srl Unipersonale have been -11% over the past three years , -3% over the past five years .

Back to Top